A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).
about
Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving targetA viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.Viral vector-based influenza vaccines.Experimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesA vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon.Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus.Biological and protective properties of immune sera directed to the influenza virus neuraminidase.Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease.Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles.Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism.Interferon-driven deletion of antiviral B cells at the onset of chronic infection.Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza.RNA replicons - a new approach for influenza virus immunoprophylaxis.Prevalence and control of H7 avian influenza viruses in birds and humans.Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles.Partial Protection against Porcine Influenza A Virus by a Hemagglutinin-Expressing Virus Replicon Particle Vaccine in the Absence of Neutralizing Antibodies.Virus replicon particles expressing porcine reproductive and respiratory syndrome virus proteins elicit immune priming but do not confer protection from viremia in pigs.Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.Development of a helper cell-dependent form of peste des petits ruminants virus: a system for making biosafe antigen.Toward RNA nanoparticle vaccines: synergizing RNA and inorganic nanoparticles to achieve immunopotentiation.Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection.A vesicular stomatitis pseudovirus expressing the surface glycoproteins of influenza A virus.Epidemiological investigations on the role of clinically healthy racing pigeons as a reservoir for avian paramyxovirus-1 and avian influenza virus.Virus replicon particle vaccines expressing nucleoprotein of influenza A virus mediate enhanced inflammatory responses in pigs.1-Benzyl-3-cetyl-2-methylimidazolium Iodide (NH125) Is a Broad-Spectrum Inhibitor of Virus Entry with Lysosomotropic Features.Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase SubtypeImmunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs
P2860
Q30227194-877A074A-5F20-4C26-BF4B-3C58248D170AQ30370147-D142109E-BDA5-4234-9076-6B2F7642728FQ30382097-A05A5F64-9B90-484E-AEAE-CE5C233C2CB9Q30390938-893511FA-A49A-4924-B8B9-7F4197693FAEQ30427591-525DD755-DE7B-4818-A139-4BDFA2469A8DQ31037459-A81442C9-0E91-452A-95CA-2EEED5277E53Q34770423-3FDDEBEF-6526-4BF6-B5CE-FC0ED1EB518FQ34991399-1C6DBD99-C64A-4D9A-9A51-7AC502ADACFBQ35746584-2A7B2826-9AF4-4D40-A77B-AA2C3668C4FCQ37281773-97F92A4D-7BD0-407D-ACEE-7BBC3D1D72DDQ37417924-DF6BB591-84E5-44B9-A8E3-1D2E12F83C88Q37423183-88092A01-7D79-4AA2-8768-56E9176981ECQ37658883-CDA27027-A731-4A09-9C41-9217E2D42C7FQ37945198-895C3BEF-C91B-4C4A-9856-54939A5CA2EBQ38178395-7BCAF040-CB6E-444E-AD4D-436B89FC62CCQ38205757-3473E86C-6F26-4049-92C2-54804BDC758BQ38436945-32CDD5D2-D55D-499E-A4CB-8CA49ED455B5Q38573583-B9E3456F-67D5-45F8-9835-3FEC99847DCEQ38741327-ABBEC63C-2AB5-4973-AF46-FE6CBAA4019BQ38833411-085B3F53-B717-42CD-9F54-4C70AFF3EAD4Q38867794-1C439844-B2C1-4A26-94C7-A9E48ADCD6F3Q39142927-A887D185-3EC3-4EEA-A143-AF0806167EB7Q42212662-06798248-5DAF-4CB1-BFC4-AEDEA1E190C0Q42241897-B351B74C-3D13-474C-9CF4-262EB03887ACQ45324179-00C48CC4-3E94-4D40-984C-09ED0197EA3EQ54976877-4C06C96E-3673-4E0A-B090-5348E704B1D9Q57093905-72E93404-9F24-423A-9C0B-304A4744C6A0Q57197569-094D80B5-94EE-4511-B12F-0B0160BF2150
P2860
A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
A recombinant vesicular stomat ...... avian influenza virus (H7N1).
@en
A recombinant vesicular stomat ...... thogenic avian influenza virus
@nl
type
label
A recombinant vesicular stomat ...... avian influenza virus (H7N1).
@en
A recombinant vesicular stomat ...... thogenic avian influenza virus
@nl
prefLabel
A recombinant vesicular stomat ...... avian influenza virus (H7N1).
@en
A recombinant vesicular stomat ...... thogenic avian influenza virus
@nl
P2093
P1433
P1476
A recombinant vesicular stomat ...... avian influenza virus (H7N1).
@en
P2093
Jutta Veits
Nazeer H Kalhoro
Silke Rautenschlein
P304
P356
10.1016/J.VACCINE.2008.12.019
P407
P50
P577
2009-01-07T00:00:00Z